| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $295,138,353 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136016 | Hepatic stellate cell plasticity and maladaptive fibrogenic memory in chronic liver disease | 000 | 4 | NIH | 2/9/2026 | $592,181 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01DA059689 | Determining the role of tripartite cell populations in THC-Induced behavioral phenotypes | 000 | 3 | NIH | 3/5/2026 | $180,847 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01MH139990 | Projection-specific mechanisms mediating postpartum stress effects on the maternal brain | 000 | 1 | NIH | 3/19/2026 | $717,688 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R13HG014713 | Training the Internal Medicine Workforce for Implementing Genomic Medicine | 000 | 1 | NIH | 3/11/2026 | $74,909 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG014190 | Niche Trajectory Analysis of Spatial Omics Data | 000 | 1 | NIH | 4/17/2026 | $2,583,834 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA303558 | Function and Therapeutic Implications of NRG3 in Breast Cancer Brain Metastasis | 000 | 1 | NIH | 5/7/2026 | $642,242 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK143032 | Modulating Iron Trafficking to Ameliorate Ineffective Erythropoiesis in MDS | 000 | 1 | NIH | 2/18/2026 | $871,028 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03DK147337 | Targeting ChREBPbeta to Protect beta-Cells from Metabolic and Inflammatory Stress in Type 1 Diabetes | 000 | 1 | NIH | 5/11/2026 | $168,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35HL184269 | Hemogenic mesoderm heterogeneity, regulation, and function | 000 | 1 | NIH | 3/12/2026 | $1,175,924 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA285425 | Organoid-immune cell culture modeling of therapeutic responses in cholangiocarcinoma | 000 | 1 | NIH | 5/12/2026 | $628,394 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1MH139952 | Moderate effect size genes in autism spectrum disorder | 000 | 2 | NIH | 5/11/2026 | $3,252,932 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R33DA056779 | Cue Reactivity Modulation in Methamphetamine Use Disorder | 000 | 3 | NIH | 3/19/2026 | $834,725 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES038499 | Chemical Mixture Exposures in Early Life: Impacts on Executive Function and Neural Circuitry Across Adolescence | 000 | 1 | NIH | 6/23/2026 | $815,546 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R33HL185498 | A streamlined base editor reengineering platform to enhance gene editing specificity and selectivity | 000 | 1 | NIH | 6/23/2026 | $570,666 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI191344 | Peptide-conjugated phosphodiamidate morpholino oligonucleotide (PPMO)-based henipavirus therapeutics | 000 | 1 | NIH | 3/30/2026 | $475,339 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NR020624 | TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer | 001 | 1 | NIH | 4/22/2026 | $83,948 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NR020624 | TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer | 000 | 1 | NIH | 2/27/2026 | $755,540 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA317668 | Reprogramming Virus-Primed Immunity for Targeted Immunotherapy of Ovarian Cancer | 000 | 1 | NIH | 6/23/2026 | $696,221 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL183204 | Metabolic Control of Immune Cell Function in Atherogenesis | 000 | 1 | NIH | 6/23/2026 | $763,862 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK147153 | Podocyte-to-parietal epithelial cell signal by exosomes drives proliferative glomerulopathy | 000 | 1 | NIH | 4/17/2026 | $816,825 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U19AI198423 | Immunologic Trajectories of Peanut Desensitization (INROADS) | 000 | 1 | NIH | 5/19/2026 | $1,444,950 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI200607 | Mapping HIV reservoir establishment in human tonsil organoids | 001 | 1 | NIH | 5/19/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI200607 | Mapping HIV reservoir establishment in human tonsil organoids | 000 | 1 | NIH | 5/19/2026 | $50,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 002 | 1 | NIH | 4/24/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 002 | 1 | NIH | 4/24/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA310749 | Improved Lung Cancer Screening Approaches for People Living with HIV | 000 | 1 | NIH | 6/23/2026 | $711,272 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 001 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 001 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 000 | 1 | NIH | 3/24/2026 | $400,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 000 | 1 | NIH | 3/24/2026 | $1,147,918 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31HL184602 | Investigating Protein Complexes in the Interferon System | 001 | 1 | NIH | 4/10/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31HL184602 | Investigating Protein Complexes in the Interferon System | 000 | 1 | NIH | 4/10/2026 | $50,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03AI196368 | Pilot project to elucidate the role of DDX60L in Ebola virus disease | 000 | 1 | NIH | 4/28/2026 | $183,875 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH142589 | The role of the ventral CA1 in distinct social representations | 000 | 1 | NIH | 4/28/2026 | $701,763 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31MH143291 | Neurocognitive Characterization of Interpersonal Dysfunction in Borderline Personality Disorder | 000 | 1 | NIH | 4/6/2026 | $49,714 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG096298 | The risk of Alzheimer's disease and related dementias among individuals with Autism Spectrum Disorder (AsDRD) | 001 | 1 | NIH | 4/24/2026 | $49,970 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG096298 | The risk of Alzheimer's disease and related dementias among individuals with Autism Spectrum Disorder (AsDRD) | 000 | 1 | NIH | 2/6/2026 | $575,377 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32HG014400 | A framework to characterize monogenic disease in founder populations using biobank-scale data | 000 | 1 | NIH | 4/27/2026 | $76,300 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99DA065809 | Dopamine receptor type 2 (D2)-expressing cells in the ventral hippocampus controlrelapse behavior | 000 | 1 | NIH | 4/21/2026 | $181,092 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01HL186236 | Causal Machine Learning and Trial Emulation for Precision Cardiovascular Risk Stratification in Obstructive Sleep Apnea (CLARITY-OSA) | 000 | 1 | NIH | 6/25/2026 | $170,892 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA299197 | Role of ATAD2 in Prostate Cancer Progression and Metastasis | 001 | 1 | NIH | 5/27/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA299197 | Role of ATAD2 in Prostate Cancer Progression and Metastasis | 000 | 1 | NIH | 4/21/2026 | $682,886 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI193023 | Defining the Role of ANKEF1 in Ciliary Function and Host Defense Against Influenza Virus Infection | 000 | 1 | NIH | 6/18/2026 | $868,915 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS146414 | A Comprehensive Genetic, Transcriptomic, and Immunohistochemical Analysis of PSP | 000 | 1 | NIH | 2/2/2026 | $669,891 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03TR006293 | Contribution of the Integrator subunit INTS12 in transcription elongation control during human erythropoiesis and in a rare congenital erythroid disorder. | 000 | 1 | NIH | 6/16/2026 | $168,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R00GM147598 | Robust atomic-level enzymatic activity study by time-resolved crystallography and computational enzymology | 000 | 3 | NIH | 1/28/2026 | $248,432 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA065015 | Single molecule functional validation of neurogenomic alterations in opioid-exposed HIV brain | 000 | 1 | NIH | 2/12/2026 | $2,352,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R00HD110939 | Maternal Childhood Maltreatment-Influenced Prenatal Programming of Early Brain-Behavior and Risk for Future Psychopathology | 000 | 3 | NIH | 2/27/2026 | $249,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32NS146143 | Controlling epilepsy symptoms with precisely timed inhibition and circuit editing | 002 | 1 | NIH | 4/1/2026 | $1,248 |
|
